Thomas E Uveges
Overview
Explore the profile of Thomas E Uveges including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion
Duan-Arnold Y, Gyurdieva A, Johnson A, Uveges T, Jacobstein D, Danilkovitch A
Adv Wound Care (New Rochelle)
. 2015 Sep;
4(9):523-533.
PMID: 26401419
Human amniotic membrane (hAM) has been used to treat wounds for more than 100 years. However, widespread use of fresh hAM has been limited due to its short shelf life...
2.
Duan-Arnold Y, Uveges T, Gyurdieva A, Johnson A, Danilkovitch A
Adv Wound Care (New Rochelle)
. 2015 Sep;
4(9):513-522.
PMID: 26339531
Chronic wounds have inadequate microvasculature (or blood vessels), resulting in poor healing. Both fresh human amniotic membrane (hAM) containing viable cells and devitalized hAM have been shown to stimulate angiogenesis...
3.
Uveges T, Kozloff K, Ty J, Ledgard F, Raggio C, Gronowicz G, et al.
J Bone Miner Res
. 2008 Dec;
24(5):849-59.
PMID: 19113917
Long courses of bisphosphonates are widely administered to children with osteogenesis imperfecta (OI), although bisphosphonates do not block mutant collagen secretion and may affect bone matrix composition or structure. The...
4.
Uveges T, Collin-Osdoby P, Cabral W, Ledgard F, Goldberg L, Bergwitz C, et al.
J Bone Miner Res
. 2008 Aug;
23(12):1983-94.
PMID: 18684089
The Brtl mouse, a knock-in model for moderately severe osteogenesis imperfecta (OI), has a G349C substitution in half of type I collagen alpha1(I) chains. We studied the cellular contribution to...
5.
Barnes A, Chang W, Morello R, Cabral W, Weis M, Eyre D, et al.
N Engl J Med
. 2006 Dec;
355(26):2757-64.
PMID: 17192541
Classic osteogenesis imperfecta, an autosomal dominant disorder associated with osteoporosis and bone fragility, is caused by mutations in the genes for type I collagen. A recessive form of the disorder...
6.
Miura Y, Miura M, Gronthos S, Allen M, Cao C, Uveges T, et al.
Proc Natl Acad Sci U S A
. 2005 Sep;
102(39):14022-7.
PMID: 16172402
Osteogenesis by the bone marrow stromal stem cells (BMSSCs) supports continuous bone formation and the homeostasis of the bone marrow microenvironment. The mechanism that controls the proliferation and differentiation of...
7.
Kozloff K, Carden A, Bergwitz C, Forlino A, Uveges T, Morris M, et al.
J Bone Miner Res
. 2004 Mar;
19(4):614-22.
PMID: 15005849
Unlabelled: The Brtl mouse model for type IV osteogenesis imperfecta improves its whole bone strength and stiffness between 2 and 6 months of age. This adaptation is accomplished without a...
8.
Uveges T, Shan Y, Kramer B, Wight D, Parysek L
J Neurosci
. 2002 Sep;
22(18):7959-67.
PMID: 12223549
The "primitive" neurons of the peripheral nervous system (PNS) have the remarkable ability to regenerate new fibers. This regenerative process requires a sequence of gene activation and repression that is...